Increased expression of GCNT1 is associated with altered O -glycosylation of PSA, PAP, and MUC1 in human prostate cancers
Authors:
- 22 May 2014
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 74 (10) , 1059-1067
Abstract
BACKGROUND Protein glycosylation is a common posttranslational modification and glycan structural changes have been observed in several malignancies including prostate cancer. We hypothesized that altered glycosylation could be related to differences in gene expression levels of glycoprotein synthetic enzymes between normal and malignant prostate tissues. METHODS We interrogated prostate cancer gene expression data for reproducible changes in expression of glycoprotein synthetic enzymes. Over‐expression of GCNT1 was validated in prostate samples using RT‐PCR. ELISA was used to measure core 2 O‐linked glycan sialyl Lewis X (sLex) of prostate specific antigen (PSA), Mucin1 (MUC1), and prostatic acidic phosphatase (PAP) proteins. RESULTS A key glycosyltransferase, GCNT1, was consistently over‐expressed in several prostate cancer gene expression datasets. RT‐PCR confirmed increased transcript levels in cancer samples compared to normal prostate tissue in fresh‐frozen prostate tissue samples. ELISA using PSA, PAP, and MUC1 capture antibodies and a specific core 2 O‐linked sLex detection antibody demonstrated elevation of this glycan structure in cancer compared to normal tissues for MUC1 (P = 0.01), PSA (P = 0.03) and near significant differences in PAP sLex levels (P = 0.06). MUC1, PSA and PAP protein levels alone were not significantly different between paired normal and malignant prostate samples. CONCLUSIONS GCNT1 is over‐expressed in prostate cancer and is associated with higher levels of core 2 O‐sLex in PSA, PAP and MUC1 proteins. Alterations of O‐linked glycosylation could be important in prostate cancer biology and could provide a new avenue for development of prostate cancer specific glycoprotein biomarkers. Prostate 74:1059–1067, 2014.Keywords
Funding Information
- Department of Defense (W81XWH-11-1-0380)
- NIH, Early Detection Research Network (1U01CA152737-01)
This publication has 40 references indexed in Scilit:
- Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune ResponsePLOS ONE, 2012
- Translational genomics: The challenge of developing cancer biomarkersGenome Research, 2012
- Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processProceedings of the National Academy of Sciences, 2011
- Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growthOncogene, 2011
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Molecular sampling of prostate cancer: a dilemma for predicting disease progressionBMC Medical Genomics, 2010
- The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomasBMC Cancer, 2009
- Mucin Glycosylation Is Altered by Pro-Inflammatory Signaling in Pancreatic-Cancer CellsJournal of Proteome Research, 2009
- Targeting selectins and selectin ligands in inflammation and cancerExpert Opinion on Therapeutic Targets, 2007
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001